CIDP/autoimmune nodopathies with nephropathy: a case series study
Abstract Objective The co‐morbidity of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)/autoimmune nodopathies with nephropathy has been gradually known in recent years. This study was intended to explore the clinical, serological and neuropathological features of seven patients with...
| Published in: | Annals of Clinical and Translational Neurology |
|---|---|
| Main Authors: | Yuwei Tang, Jing Liu, Feng Gao, Hongjun Hao, Zhirong Jia, Wei Zhang, Xin Shi, Wei Liang, Meng Yu, He Lv, Ying Tan, Zhiying Li, Yu Wang, Yun Yuan, Lingchao Meng, Zhaoxia Wang |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-05-01
|
| Online Access: | https://doi.org/10.1002/acn3.51754 |
Similar Items
Comparison of the presentation and electrophysiological characteristics of autoimmune nodopathies in patients with antibody-negative CIDP and CMT1
by: Changdong Song, et al.
Published: (2025-09-01)
by: Changdong Song, et al.
Published: (2025-09-01)
Ofatumumab for the Treatment of Anti‐Neurofascin 155 Autoimmune Nodopathy: A Case Series
by: Kalam Choi, et al.
Published: (2025-08-01)
by: Kalam Choi, et al.
Published: (2025-08-01)
Clinical characteristics of anti‐neurofascin 155 antibody‐positive autoimmune nodopathy in children
by: Liya Cui, et al.
Published: (2025-09-01)
by: Liya Cui, et al.
Published: (2025-09-01)
Clinical profile of autoimmune nodopathy with anti‐neurofascin 186 antibody
by: Bingyou Liu, et al.
Published: (2023-06-01)
by: Bingyou Liu, et al.
Published: (2023-06-01)
Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
by: Yunfei Bai, et al.
Published: (2023-03-01)
by: Yunfei Bai, et al.
Published: (2023-03-01)
Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies
by: Jiwei Zhang, et al.
Published: (2024-04-01)
by: Jiwei Zhang, et al.
Published: (2024-04-01)
Favorable long-term outcomes of autoimmune nodopathy with mycophenolate mofetil
by: Young Gi Min, et al.
Published: (2024-12-01)
by: Young Gi Min, et al.
Published: (2024-12-01)
Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody
by: Ying Hou, et al.
Published: (2022-07-01)
by: Ying Hou, et al.
Published: (2022-07-01)
Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy
by: Lijun Wang, et al.
Published: (2022-11-01)
by: Lijun Wang, et al.
Published: (2022-11-01)
Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies
by: Wanyu Wang, et al.
Published: (2022-09-01)
by: Wanyu Wang, et al.
Published: (2022-09-01)
Anti-contactin-1 autoimmune nodopathy with thymoma: case report and literature review
by: Takumi Tashiro, et al.
Published: (2025-09-01)
by: Takumi Tashiro, et al.
Published: (2025-09-01)
Case report: target antigen and subclass switch in a patient with autoimmune nodopathy
by: Luise Appeltshauser, et al.
Published: (2024-10-01)
by: Luise Appeltshauser, et al.
Published: (2024-10-01)
Case Report: CASPR2-associated autoimmune encephalitis with NF155 Antibody-positive autoimmune nodopathies: a rare case with hyponatremia onset
by: Wen-Ya Wang, et al.
Published: (2025-03-01)
by: Wen-Ya Wang, et al.
Published: (2025-03-01)
Super-resolution of nodal and paranodal disruption in anti-pan-neurofascin-associated autoimmune nodopathy
by: Vinicius da Cruz Neris Geßner, et al.
Published: (2025-02-01)
by: Vinicius da Cruz Neris Geßner, et al.
Published: (2025-02-01)
Therapy-resistant autoimmune nodopathy with anti-neurofascin 155 antibodies: a case report
by: Teodors Talers, et al.
Published: (2024-07-01)
by: Teodors Talers, et al.
Published: (2024-07-01)
Autoimmune nodopathy with anti-NF186 antibodies following SARS-CoV-2 infection: a case report
by: Junmei Lai, et al.
Published: (2025-09-01)
by: Junmei Lai, et al.
Published: (2025-09-01)
Autoimmune nodopathy with anti-contactin 1 antibody characterized by cerebellar dysarthria: a case report and literature review
by: Jiajie Chen, et al.
Published: (2024-03-01)
by: Jiajie Chen, et al.
Published: (2024-03-01)
Short-term treatment of CIDP with efgartigimod: a case series in China
by: Chong Sun, et al.
Published: (2025-05-01)
by: Chong Sun, et al.
Published: (2025-05-01)
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients
by: Amina A. Abdelhadi, et al.
Published: (2025-05-01)
by: Amina A. Abdelhadi, et al.
Published: (2025-05-01)
The Misdiagnosis of CIDP: A Review
by: Jeffrey A. Allen
Published: (2020-03-01)
by: Jeffrey A. Allen
Published: (2020-03-01)
Neuropatia da Hanseníase versus CIDP
by: Marco Minchola Robles, et al.
Published: (2012-06-01)
by: Marco Minchola Robles, et al.
Published: (2012-06-01)
Is nerve biopsy useful in diagnosis of CIDP?
by: Ioana Mindruta, et al.
Published: (2011-03-01)
by: Ioana Mindruta, et al.
Published: (2011-03-01)
Typical CIDP, distal variant CIDP, and anti-MAG antibody neuropathy: An ultra-high frequency ultrasound comparison of nerve structure
by: Angela Puma, et al.
Published: (2024-02-01)
by: Angela Puma, et al.
Published: (2024-02-01)
Nerve ultrasound: Unravelling the different patterns of nerve enlargement in CIDP subtypes
by: Cheng-Yin Tan, et al.
Published: (2023-01-01)
by: Cheng-Yin Tan, et al.
Published: (2023-01-01)
Chronic inflammatory demyelinating polyneuropathy with hypoglossal nerve involvement and inverted Beevor’s sign: case report
by: Huajian Zhao, et al.
Published: (2021-06-01)
by: Huajian Zhao, et al.
Published: (2021-06-01)
Successfully salvaging a HIV-positive patient with mixed CIDP and meningoencephalitis: a case report
by: Wen Wang, et al.
Published: (2025-03-01)
by: Wen Wang, et al.
Published: (2025-03-01)
Successful treatment of relapsed and refractory CIDP with ofatumumab: a first case report
by: Jian Wang, et al.
Published: (2024-07-01)
by: Jian Wang, et al.
Published: (2024-07-01)
Skeletal Muscle Involvement Pattern of Hereditary Transthyretin Amyloidosis: A Study Based on Muscle MRI
by: Xujun Chu, et al.
Published: (2022-05-01)
by: Xujun Chu, et al.
Published: (2022-05-01)
Recurrent CNTN1 antibody-positive nodopathy: a case report and literature review
by: Min Zhao, et al.
Published: (2024-05-01)
by: Min Zhao, et al.
Published: (2024-05-01)
Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
by: Alon Abraham, et al.
Published: (2015-01-01)
by: Alon Abraham, et al.
Published: (2015-01-01)
Intestinal microflora dysbiosis and resistome in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
by: Katia Djenadi, et al.
Published: (2024-09-01)
by: Katia Djenadi, et al.
Published: (2024-09-01)
Retrospective correlation analysis of plasma Immunoglobulin G and clinical performance in CIDP
by: Lars Kjøbsted Markvardsen, et al.
Published: (2019-05-01)
by: Lars Kjøbsted Markvardsen, et al.
Published: (2019-05-01)
Access to Immunoglobulin Treatment for CIDP Patients During the COVID-19 Pandemic
by: Vincent Brissette, et al.
Published: (2023-08-01)
by: Vincent Brissette, et al.
Published: (2023-08-01)
CIDP: Current Treatments and Identification of Targets for Future Specific Therapeutic Intervention
by: Susana Brun, et al.
Published: (2022-01-01)
by: Susana Brun, et al.
Published: (2022-01-01)
Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis
by: Dario Ricciardi, et al.
Published: (2022-11-01)
by: Dario Ricciardi, et al.
Published: (2022-11-01)
Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies
by: Yijun Ren, et al.
Published: (2023-10-01)
by: Yijun Ren, et al.
Published: (2023-10-01)
Telitacicept for autoimmune nephropathy
by: Jingjing Cai, et al.
Published: (2023-06-01)
by: Jingjing Cai, et al.
Published: (2023-06-01)
A rare case of membranous nephropathy associated with chronic inflammatory demyelinating polyradiculoneuropathy
by: Qiong Zhang, et al.
Published: (2023-12-01)
by: Qiong Zhang, et al.
Published: (2023-12-01)
Young Male with Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy (A-CIDP)
by: Shalesh Rohatgi, et al.
Published: (2024-10-01)
by: Shalesh Rohatgi, et al.
Published: (2024-10-01)
A Rare Presentation of Patient With CIDP Found to Have Respiratory Failure and Encephalopathy
by: Pankti Sheth, et al.
Published: (2025-01-01)
by: Pankti Sheth, et al.
Published: (2025-01-01)
Similar Items
-
Comparison of the presentation and electrophysiological characteristics of autoimmune nodopathies in patients with antibody-negative CIDP and CMT1
by: Changdong Song, et al.
Published: (2025-09-01) -
Ofatumumab for the Treatment of Anti‐Neurofascin 155 Autoimmune Nodopathy: A Case Series
by: Kalam Choi, et al.
Published: (2025-08-01) -
Clinical characteristics of anti‐neurofascin 155 antibody‐positive autoimmune nodopathy in children
by: Liya Cui, et al.
Published: (2025-09-01) -
Clinical profile of autoimmune nodopathy with anti‐neurofascin 186 antibody
by: Bingyou Liu, et al.
Published: (2023-06-01) -
Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
by: Yunfei Bai, et al.
Published: (2023-03-01)
